Monday, 17 Feb 2020

Biologic/Novel Rx

Datesort ascending Type Title Save
13 Mar 2019 ACR Video QD Clinic - Secondary Loss of Efficacy
13 Mar 2019 News First Line IL-1 Inhibition in Systemic JIA
11 Mar 2019 ACR Video QD Clinic - Biologic Class Switching
25 Feb 2019 Social ERRATA: "How to Handle Latex Allergies and Biologics" - has been corrected to show that the Cimzia PFS DOES contain 7% of a plastic derived from natural rubber latex. Latex- sensitive patients should be advised to handle the needle shield with caution. https://t.co/ThLns4C5Jt
22 Feb 2019 ACR Video QD Clinic - Rules for Pregnancy
20 Feb 2019 News Impressive Survival of Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
20 Feb 2019 News Safety Warnings for Higher Dose Tofacitinib
19 Feb 2019 ACR Video QD Clinic - When to Stop Anakinra
18 Feb 2019 ACR Video QD Clinic - The NP Says the Patient is Flaring
16 Feb 2019 Social The RheumNow Weekly Podcast is up! Info on SEAM-PsA, SEAM trial, MRI T2T, biologics & infection, contraceptive use, ANA negative lupus. View here>> https://t.co/tv2ANE0LAp or listen on iTunes or SoundClound https://t.co/uXZEI1jmkJ
16 Feb 2019 Social Dr Mark Genovese on Filgotinib (jak 1 inhibitor in development) showing no diff in responses despite falling 1, 2, 3 biologics #RWCS2019 https://t.co/dk7orkumEd
14 Feb 2019 News Stopping Biologics Before Joint Surgery: Is Earlier Better?
06 Feb 2019 News Biologic High Out of Pocket Costs for Medicare Patients
31 Jan 2019 Social The rheumatoid arthritis drug Xeljanz saw revenues jump 33% for the year, with total revenues coming in at $1.8 billion in 2018 https://t.co/E7KHJSgkjF
25 Jan 2019 News RheumNow Podcast – TNFs and the Inflammasome (1.25.19)
21 Jan 2019 News Smoking Doesn't Influence Rituximab Responses in Rheumatoid Arthritis
16 Jan 2019 News Anakinra for Acute Crystal-Induced Arthritis
15 Jan 2019 News IL-6 Blocker Succeeds in Real-World Vasculitis
11 Jan 2019 Social “The road to hell is paved with biologic plausibility”. - Dr. Steve Nissan
07 Jan 2019 News BMS Buyout of Celgene for $74 Billion